Regencell Bioscience Holdings Limited (RGC): Projected Future Earnings
Regencell Bioscience (RGC) develops treatments for ADHD and ASD by merging science with traditional Chinese medicine. The future profit trajectory demonstrates asset revaluation inertia, where the mark captures this metric. However, its venture status and narrow niche limit growth, while geopolitical tensions between East and West create significant regulatory barriers to expansion.
Analytical breakdowns for Regencell Bioscience
- share price and consensus valuation forecast:
- stock exchange capitalization data:
- book capitalization indicators:
- debt level and financial liquidity data:
Total Debt to Capital Regencell Bioscience|RGC - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital Regencell|RGC - Company Cumulative Debt|Debt to Book Capitalization Ratio Regencell Bioscience|RGC - Company Long-Term Debt|Company Short-Term Debt Regencell Bioscience|Quick Liquidity Indicator regencellbioscience.com
- earnings and valuation multiples information:
RGC - Final Profit|Projected Future Earnings Regencell Bioscience|RGC - Price to Earnings Ratio|Forward P/E Multiple Regencell Bioscience Holdings Limited|RGC - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Regencell Bioscience|RGC - Profit before interest, taxes and amortization|Earnings per share for the last twelve months Regencell Bioscience|RGC - Net earnings per share for the last four quarters|Quarterly EPS earnings growth regencellbioscience.com|RGC - Net earnings per share growth this year|Earnings growth forecast for next year Regencell Bioscience
Fundamental company analysis:RGC, Regencell Bioscience
The automation of ADHD drug synthesis at Regencell Bioscience (RGC) defines its revenue growth potential, although reliance on clinical medical supervision creates volatility in expectations. Analyzing the forward earnings chart, an investor can see aggregated analyst forecasts for net income over future periods, which allows them to filter out market noise and assess the business's real value through the lens of future cash flows.
Key competitors
BIIB (Biogen Inc.) - Projected Future Earnings|Expected Net Profit neurocrine.com NBIX|Projected Future Earnings AXSM|ACADIA Pharma (ACAD) - Projected Net Profit|Projected Future Earnings XENE (Xenon Pharmaceuticals Inc)|Viking Therapeutics Corp (VKTX) - Expected Net Profit|SUPN - Expected Profit|CPRX (catalystpharma.com) - Net Profit Forecast|DNLI: Projected Future Earnings|Future Profit Harmony Biosciences Inc|BHVN (Biohaven Pharmaceutical) - Projected Future Earnings|Expected Net Profit Amylyx Corp AMLX|Expected Profit Trevi Therapeutics (TRVI)|Expected Profit PRAX (praxismedicines.com)|Expected Profit Anavex Life Sciences Corp. AVXL|CeriBell Inc - Expected Profit|PRTA: Future Profit|Expected Net Income ALEC (Alector, Inc.)|ANNX: Projected Future Earnings|OMER (Omeros) - Expected Profit|NGNE (Neurogene) - Projected Future Earnings|AC Immune S.A. (ACIU) - Company Profit Forecast|Expected Profit Voyager Pharma (VYGR)|NMRA - Expected Net Profit|Expected Profit Scilex Holding Company SCLX|Company Profit Forecast tevogen.com (TVGN)|Alpha Cognition Corp - Projected Future Earnings|cogrx.com (CGTX) - Future Profit|IKT: Projected Future Earnings|SAVA - Company Profit Forecast|ASRT (Assertio Holdings) - Projected Future Earnings|Expected Net Profit Coya COYA|Expected Profit Vistagen Therapeutics (VTGN)|ovidrx.com - Net Profit Forecast|Projected Future Earnings ABOS (Acumen Pharma)|CRVO - Future Profit|Alterity Therapeutics Ltd - Projected Future Earnings|Expected Net Profit Clene Inc.|pepgen.com (PEPG) - Expected Profit|jupiterneurosciences.com - Expected Net Income|RLMD (Relmada) - Projected Future Earnings|ANVS - Projected Net Profit|Projected Future Earnings GRCE|Future Profit fireflyneuro.com AIFF|Expected Profit Klotho Neurosciences KLTO|NRSN: Net Profit Forecast|Reviva Pharmaceuticals Holdings - Projected Future Earnings|Expected Net Profit MetaVia Inc|NRXS (NeurAxis, Inc.) - Future Profit|Helius Medical Technologies (HSDT) - Projected Future Earnings|Expected Profit Passage Bio Inc.|NEUP: Expected Net Income|Expected Profit Minerva Neurosciences Corp (NERV)|ATHA - Expected Net Profit|Expected Profit Addex Therapeutics ADXN|Expected Net Income ALZN|Cyclerion - Projected Future Earnings|Expected Net Profit Protagenic Therapeutics|KTTA: Projected Future Earnings|Projected Net Profit Cortigent CRGT|ATXI (Avenue Therapeutics) - Projected Future Earnings|Expected Net Profit brainstorm-cell.com BCLI|Expected Profit Cara Therapeutics (CARA)|Chromocell Therapeutics Corp - Net Profit Forecast|Projected Future Earnings ELYM (Eliem Therapeutics Inc.)|ITCI - Future Profit|Longboard Pharmaceuticals - Projected Future Earnings|Expected Net Profit marinuspharma.com|NKGen Biotech (NKGN) - Expected Profit|NRBO (NeuroBo Pharmaceuticals Inc) - Expected Profit|Expected Profit Sage Therapeutics, Inc|Expected Profit SNPX|Future Profit TRVN (Trevena, Inc.)|VIGL (vigilneuro.com) - Expected Net Income|Projected Future Earnings WENA (Anew Medical, Inc.)|Cerevel Therapeutics Inc - Expected Profit
